Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 53 | 2024 | 5145 | 3.480 |
Why?
|
von Willebrand Factor | 8 | 2023 | 677 | 2.120 |
Why?
|
Anatomy, Artistic | 3 | 2020 | 51 | 1.510 |
Why?
|
Nerve Transfer | 13 | 2020 | 128 | 1.240 |
Why?
|
Cubital Tunnel Syndrome | 5 | 2022 | 34 | 1.200 |
Why?
|
Neoplasm, Residual | 2 | 2024 | 1008 | 1.190 |
Why?
|
Video Recording | 2 | 2020 | 965 | 0.980 |
Why?
|
National Socialism | 3 | 2020 | 54 | 0.930 |
Why?
|
Bone Density Conservation Agents | 4 | 2022 | 795 | 0.920 |
Why?
|
Ulnar Nerve | 9 | 2020 | 102 | 0.900 |
Why?
|
Neurosurgery | 3 | 2020 | 679 | 0.870 |
Why?
|
Nerve Compression Syndromes | 3 | 2022 | 160 | 0.850 |
Why?
|
Factor VIII | 2 | 2015 | 349 | 0.810 |
Why?
|
Electroosmosis | 1 | 2021 | 8 | 0.790 |
Why?
|
Hypercalcemia | 2 | 2022 | 423 | 0.780 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 196 | 0.770 |
Why?
|
Medical Illustration | 2 | 2018 | 135 | 0.730 |
Why?
|
Education, Distance | 1 | 2022 | 260 | 0.630 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2018 | 141 | 0.610 |
Why?
|
Peripheral Nervous System | 1 | 2019 | 151 | 0.590 |
Why?
|
Atlases as Topic | 1 | 2019 | 247 | 0.580 |
Why?
|
Carpal Tunnel Syndrome | 2 | 2020 | 303 | 0.560 |
Why?
|
Ethylene Glycols | 4 | 2024 | 196 | 0.550 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 11 | 2024 | 11732 | 0.540 |
Why?
|
Median Nerve | 5 | 2020 | 131 | 0.490 |
Why?
|
RANK Ligand | 2 | 2017 | 318 | 0.490 |
Why?
|
Neuralgia | 2 | 2018 | 612 | 0.460 |
Why?
|
Bone Diseases | 1 | 2017 | 418 | 0.450 |
Why?
|
Blood Platelets | 3 | 2019 | 2477 | 0.440 |
Why?
|
Education, Medical, Graduate | 3 | 2020 | 2372 | 0.430 |
Why?
|
Clinical Competence | 7 | 2023 | 4786 | 0.420 |
Why?
|
Dexamethasone | 7 | 2024 | 1945 | 0.420 |
Why?
|
Brachial Plexus | 5 | 2018 | 167 | 0.410 |
Why?
|
Aniline Compounds | 4 | 2024 | 1073 | 0.410 |
Why?
|
Bone Neoplasms | 2 | 2022 | 2527 | 0.410 |
Why?
|
Thalidomide | 4 | 2024 | 885 | 0.400 |
Why?
|
Peripheral Nerves | 4 | 2020 | 479 | 0.400 |
Why?
|
General Surgery | 3 | 2020 | 1692 | 0.370 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2022 | 278 | 0.370 |
Why?
|
Radial Nerve | 4 | 2022 | 42 | 0.370 |
Why?
|
Hemostasis | 1 | 2013 | 470 | 0.370 |
Why?
|
Diphosphonates | 4 | 2022 | 636 | 0.360 |
Why?
|
Medicine | 1 | 2018 | 942 | 0.350 |
Why?
|
Bacteriophages | 1 | 2013 | 378 | 0.340 |
Why?
|
Stem Cell Transplantation | 4 | 2022 | 1600 | 0.340 |
Why?
|
Humans | 127 | 2024 | 761098 | 0.330 |
Why?
|
Hydrazines | 3 | 2020 | 222 | 0.330 |
Why?
|
Antigens, CD19 | 2 | 2024 | 424 | 0.320 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3634 | 0.320 |
Why?
|
B-Cell Maturation Antigen | 3 | 2024 | 149 | 0.320 |
Why?
|
Radial Neuropathy | 2 | 2022 | 26 | 0.320 |
Why?
|
Oligopeptides | 3 | 2024 | 1178 | 0.310 |
Why?
|
Holocaust | 2 | 2019 | 36 | 0.310 |
Why?
|
Protein Multimerization | 1 | 2013 | 974 | 0.310 |
Why?
|
Antineoplastic Agents | 9 | 2024 | 13630 | 0.310 |
Why?
|
Internet | 1 | 2020 | 3094 | 0.310 |
Why?
|
Osteoclasts | 4 | 2017 | 711 | 0.300 |
Why?
|
Fluorine Radioisotopes | 3 | 2020 | 420 | 0.300 |
Why?
|
Karyopherins | 2 | 2019 | 133 | 0.300 |
Why?
|
Dissection | 2 | 2020 | 297 | 0.300 |
Why?
|
Immunotherapy, Adoptive | 6 | 2023 | 1468 | 0.300 |
Why?
|
Orthotic Devices | 1 | 2008 | 130 | 0.290 |
Why?
|
Pulsatile Flow | 2 | 2008 | 320 | 0.290 |
Why?
|
Robotics | 2 | 2023 | 818 | 0.270 |
Why?
|
Mechanotransduction, Cellular | 2 | 2008 | 528 | 0.260 |
Why?
|
Triazoles | 3 | 2020 | 903 | 0.250 |
Why?
|
Pipecolic Acids | 1 | 2006 | 77 | 0.250 |
Why?
|
Nerve Regeneration | 7 | 2015 | 796 | 0.250 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 2 | 2018 | 179 | 0.250 |
Why?
|
Models, Molecular | 1 | 2015 | 5413 | 0.240 |
Why?
|
Peptide Fragments | 2 | 2015 | 5103 | 0.240 |
Why?
|
Ikaros Transcription Factor | 2 | 2024 | 232 | 0.240 |
Why?
|
Decompression, Surgical | 4 | 2022 | 607 | 0.240 |
Why?
|
Bone Marrow | 4 | 2020 | 2911 | 0.230 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2012 | 1520 | 0.230 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 858 | 0.230 |
Why?
|
Blood Flow Velocity | 1 | 2008 | 1374 | 0.230 |
Why?
|
Fatigue | 3 | 2022 | 1550 | 0.220 |
Why?
|
Pyrimidines | 4 | 2018 | 3026 | 0.220 |
Why?
|
ADAM Proteins | 2 | 2015 | 238 | 0.220 |
Why?
|
Endothelial Cells | 3 | 2019 | 3550 | 0.220 |
Why?
|
Spinal Diseases | 1 | 2008 | 562 | 0.220 |
Why?
|
Melphalan | 2 | 2022 | 420 | 0.220 |
Why?
|
Protein Structure, Quaternary | 2 | 2015 | 427 | 0.220 |
Why?
|
Thrombin | 1 | 2006 | 593 | 0.220 |
Why?
|
Amyloidosis | 2 | 2021 | 864 | 0.210 |
Why?
|
Hydroxamic Acids | 2 | 2016 | 479 | 0.210 |
Why?
|
Osteoporosis | 1 | 2012 | 1604 | 0.210 |
Why?
|
Internship and Residency | 2 | 2020 | 5879 | 0.200 |
Why?
|
Coffee | 1 | 2007 | 592 | 0.200 |
Why?
|
Models, Cardiovascular | 1 | 2008 | 983 | 0.200 |
Why?
|
Suspensions | 1 | 2021 | 66 | 0.200 |
Why?
|
Thrombocytopenia | 3 | 2020 | 1182 | 0.200 |
Why?
|
Hand | 3 | 2012 | 902 | 0.200 |
Why?
|
Hemorrhage | 1 | 2013 | 3422 | 0.190 |
Why?
|
Automobile Driving | 1 | 2007 | 441 | 0.190 |
Why?
|
Aged | 38 | 2024 | 169266 | 0.190 |
Why?
|
Osteonecrosis | 2 | 2014 | 230 | 0.190 |
Why?
|
Middle Aged | 40 | 2024 | 220835 | 0.190 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2022 | 629 | 0.180 |
Why?
|
Serpins | 1 | 2022 | 247 | 0.180 |
Why?
|
Cardiomyopathies | 3 | 2024 | 2021 | 0.180 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2021 | 1074 | 0.180 |
Why?
|
von Willebrand Diseases | 1 | 2022 | 132 | 0.180 |
Why?
|
History, 20th Century | 2 | 2019 | 2764 | 0.180 |
Why?
|
Hernia, Inguinal | 1 | 2023 | 220 | 0.180 |
Why?
|
Male | 52 | 2024 | 360675 | 0.180 |
Why?
|
Hemostatics | 1 | 2022 | 240 | 0.170 |
Why?
|
Treatment Outcome | 19 | 2024 | 64670 | 0.170 |
Why?
|
Female | 45 | 2024 | 392458 | 0.170 |
Why?
|
Imidazoles | 2 | 2017 | 1173 | 0.170 |
Why?
|
Muscle, Skeletal | 6 | 2020 | 4947 | 0.170 |
Why?
|
Medication Errors | 1 | 2006 | 783 | 0.170 |
Why?
|
Receptors, CXCR4 | 2 | 2021 | 727 | 0.160 |
Why?
|
Audiovisual Aids | 1 | 2020 | 99 | 0.160 |
Why?
|
Factor XII | 1 | 2018 | 19 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1923 | 0.160 |
Why?
|
Arm Injuries | 1 | 2020 | 156 | 0.160 |
Why?
|
Lumbar Vertebrae | 1 | 2008 | 1876 | 0.160 |
Why?
|
Neurotoxicity Syndromes | 1 | 2023 | 301 | 0.160 |
Why?
|
Phosphoramide Mustards | 1 | 2018 | 18 | 0.160 |
Why?
|
Radiopharmaceuticals | 4 | 2024 | 2682 | 0.160 |
Why?
|
Nitric Oxide | 1 | 2008 | 2135 | 0.160 |
Why?
|
Spinal Fusion | 1 | 2008 | 1294 | 0.160 |
Why?
|
Metalloproteases | 1 | 2018 | 61 | 0.160 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2021 | 638 | 0.150 |
Why?
|
Adenine | 2 | 2021 | 986 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2024 | 629 | 0.150 |
Why?
|
Sciatic Nerve | 3 | 2010 | 618 | 0.150 |
Why?
|
Cadaver | 2 | 2020 | 1358 | 0.150 |
Why?
|
Quality of Life | 7 | 2024 | 13362 | 0.150 |
Why?
|
World War II | 1 | 2018 | 61 | 0.150 |
Why?
|
Gene Expression Regulation | 4 | 2019 | 11856 | 0.150 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2021 | 617 | 0.150 |
Why?
|
Leukemia, Plasma Cell | 1 | 2018 | 46 | 0.150 |
Why?
|
Organizational Innovation | 1 | 2021 | 538 | 0.150 |
Why?
|
Acinetobacter baumannii | 1 | 2018 | 117 | 0.150 |
Why?
|
Nitroimidazoles | 1 | 2018 | 117 | 0.140 |
Why?
|
Sodium Fluoride | 1 | 2017 | 66 | 0.140 |
Why?
|
Abdomen | 1 | 2023 | 1128 | 0.140 |
Why?
|
Morpholines | 2 | 2024 | 581 | 0.140 |
Why?
|
Peptide Library | 2 | 2015 | 347 | 0.140 |
Why?
|
Protein Biosynthesis | 2 | 2019 | 2091 | 0.140 |
Why?
|
Bone and Bones | 2 | 2017 | 2567 | 0.140 |
Why?
|
Immunoconjugates | 1 | 2024 | 963 | 0.140 |
Why?
|
Muscular Atrophy | 1 | 2020 | 334 | 0.140 |
Why?
|
Certification | 1 | 2020 | 418 | 0.140 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2021 | 1060 | 0.140 |
Why?
|
Adult | 27 | 2024 | 221083 | 0.130 |
Why?
|
Whole Body Imaging | 1 | 2018 | 284 | 0.130 |
Why?
|
Transplantation, Autologous | 5 | 2022 | 2112 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2024 | 5300 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2012 | 9185 | 0.130 |
Why?
|
Gene Amplification | 1 | 2021 | 1084 | 0.130 |
Why?
|
Pilot Projects | 4 | 2023 | 8639 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 898 | 0.130 |
Why?
|
Gynecology | 1 | 2022 | 526 | 0.130 |
Why?
|
POEMS Syndrome | 1 | 2015 | 12 | 0.130 |
Why?
|
Pulmonary Heart Disease | 1 | 2015 | 34 | 0.130 |
Why?
|
Osteolysis | 1 | 2017 | 275 | 0.130 |
Why?
|
Piperidines | 2 | 2021 | 1656 | 0.130 |
Why?
|
Decorin | 1 | 2015 | 38 | 0.120 |
Why?
|
Intercostal Nerves | 1 | 2015 | 28 | 0.120 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 8000 | 0.120 |
Why?
|
Isoxazoles | 1 | 2016 | 233 | 0.120 |
Why?
|
Obstetrics | 1 | 2022 | 666 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20600 | 0.120 |
Why?
|
Neurologic Examination | 1 | 2018 | 915 | 0.120 |
Why?
|
Benzazepines | 1 | 2016 | 310 | 0.120 |
Why?
|
Abdominal Fat | 1 | 2016 | 221 | 0.120 |
Why?
|
Hematologic Neoplasms | 2 | 2022 | 1895 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2016 | 773 | 0.120 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2011 | 709 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2017 | 1650 | 0.110 |
Why?
|
Surgery, Plastic | 1 | 2021 | 641 | 0.110 |
Why?
|
Polyneuropathies | 1 | 2015 | 137 | 0.110 |
Why?
|
Bone Diseases, Metabolic | 1 | 2017 | 410 | 0.110 |
Why?
|
Hyperalgesia | 1 | 2018 | 526 | 0.110 |
Why?
|
Mice, 129 Strain | 1 | 2014 | 370 | 0.110 |
Why?
|
Lymphoma | 1 | 2022 | 1898 | 0.110 |
Why?
|
Structure-Activity Relationship | 2 | 2021 | 3060 | 0.110 |
Why?
|
Peptide Mapping | 1 | 2013 | 259 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5667 | 0.110 |
Why?
|
Metalloendopeptidases | 1 | 2015 | 389 | 0.110 |
Why?
|
Fatty Acids | 1 | 2001 | 1806 | 0.110 |
Why?
|
Neurosurgical Procedures | 3 | 2015 | 2067 | 0.110 |
Why?
|
Educational Measurement | 1 | 2020 | 1251 | 0.110 |
Why?
|
Anilides | 1 | 2016 | 411 | 0.110 |
Why?
|
Genetic Heterogeneity | 1 | 2016 | 734 | 0.110 |
Why?
|
Mutagenesis | 2 | 2015 | 1227 | 0.110 |
Why?
|
Prospective Studies | 9 | 2024 | 54419 | 0.100 |
Why?
|
Learning | 1 | 2022 | 1739 | 0.100 |
Why?
|
Lymphoma, B-Cell | 1 | 2019 | 938 | 0.100 |
Why?
|
Paraproteinemias | 1 | 2015 | 250 | 0.100 |
Why?
|
Neoplasms | 2 | 2021 | 22125 | 0.100 |
Why?
|
Thoracic Surgery | 1 | 2018 | 722 | 0.100 |
Why?
|
Protein Stability | 1 | 2014 | 576 | 0.100 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2014 | 282 | 0.100 |
Why?
|
Acrylamides | 1 | 2014 | 259 | 0.100 |
Why?
|
Nerve Tissue | 1 | 2012 | 78 | 0.100 |
Why?
|
Recovery of Function | 7 | 2020 | 2981 | 0.100 |
Why?
|
Arm | 2 | 2015 | 589 | 0.100 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 448 | 0.100 |
Why?
|
Nerve Block | 1 | 2018 | 705 | 0.100 |
Why?
|
Aged, 80 and over | 14 | 2024 | 58946 | 0.100 |
Why?
|
Microscopy, Electron | 1 | 2015 | 2562 | 0.100 |
Why?
|
Thoracic Nerves | 1 | 2011 | 20 | 0.100 |
Why?
|
History, 21st Century | 1 | 2018 | 1566 | 0.100 |
Why?
|
Laparoscopy | 1 | 2023 | 2030 | 0.100 |
Why?
|
Activins | 1 | 2013 | 210 | 0.090 |
Why?
|
Immunotherapy | 3 | 2022 | 4642 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2021 | 5870 | 0.090 |
Why?
|
Brachial Plexus Neuritis | 1 | 2010 | 20 | 0.090 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1038 | 0.090 |
Why?
|
Teaching | 1 | 2018 | 1169 | 0.090 |
Why?
|
Sleep | 1 | 2007 | 4761 | 0.090 |
Why?
|
Disease Management | 1 | 2021 | 2508 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2024 | 9278 | 0.090 |
Why?
|
Motor Endplate | 1 | 2010 | 20 | 0.090 |
Why?
|
Myocardium | 2 | 2021 | 4746 | 0.090 |
Why?
|
Preoperative Care | 2 | 2017 | 2242 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1640 | 0.090 |
Why?
|
Bone Remodeling | 1 | 2014 | 583 | 0.090 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 66 | 0.090 |
Why?
|
Recurrence | 4 | 2021 | 8456 | 0.090 |
Why?
|
Retreatment | 2 | 2024 | 598 | 0.090 |
Why?
|
Anticoagulants | 1 | 2006 | 4795 | 0.090 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7574 | 0.090 |
Why?
|
Forearm | 1 | 2012 | 427 | 0.090 |
Why?
|
Life Style | 1 | 2021 | 3908 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 943 | 0.080 |
Why?
|
Paralysis | 1 | 2011 | 250 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1784 | 0.080 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2011 | 122 | 0.080 |
Why?
|
Sciatic Neuropathy | 1 | 2010 | 76 | 0.080 |
Why?
|
Schwann Cells | 1 | 2010 | 196 | 0.080 |
Why?
|
Animals | 23 | 2024 | 168083 | 0.080 |
Why?
|
Disease Progression | 4 | 2022 | 13506 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 2 | 2014 | 3725 | 0.080 |
Why?
|
DNA Primers | 1 | 2013 | 2815 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2001 | 3594 | 0.080 |
Why?
|
Mutation | 9 | 2022 | 30006 | 0.080 |
Why?
|
Thrombosis | 1 | 2022 | 2944 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1624 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4405 | 0.080 |
Why?
|
Spinal Cord Diseases | 1 | 2010 | 291 | 0.070 |
Why?
|
Pyrazoles | 1 | 2018 | 2010 | 0.070 |
Why?
|
Sensation | 1 | 2009 | 336 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1113 | 0.070 |
Why?
|
Mice | 15 | 2019 | 81324 | 0.070 |
Why?
|
Membranes, Artificial | 1 | 2009 | 366 | 0.070 |
Why?
|
Shear Strength | 1 | 2008 | 160 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2001 | 3951 | 0.070 |
Why?
|
Cell Line, Tumor | 7 | 2021 | 16947 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1540 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1643 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3779 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3739 | 0.070 |
Why?
|
Umbilical Veins | 1 | 2007 | 423 | 0.070 |
Why?
|
Administration, Oral | 3 | 2019 | 4014 | 0.070 |
Why?
|
Heart Failure | 2 | 2024 | 11701 | 0.070 |
Why?
|
Postoperative Care | 2 | 2012 | 1469 | 0.070 |
Why?
|
Cell Movement | 2 | 2010 | 5195 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2018 | 8519 | 0.060 |
Why?
|
Biopsy | 3 | 2019 | 6781 | 0.060 |
Why?
|
Tumor Microenvironment | 2 | 2017 | 3869 | 0.060 |
Why?
|
Hyaluronic Acid | 1 | 2009 | 484 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 6585 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.060 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3838 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2007 | 3114 | 0.060 |
Why?
|
Blood Component Transfusion | 1 | 2006 | 142 | 0.060 |
Why?
|
Neoplasm Staging | 4 | 2018 | 11118 | 0.060 |
Why?
|
Disease-Free Survival | 3 | 2022 | 6817 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5872 | 0.060 |
Why?
|
Th1 Cells | 1 | 2010 | 1042 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20120 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 12743 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2426 | 0.060 |
Why?
|
Pain, Postoperative | 1 | 2015 | 1738 | 0.060 |
Why?
|
Phthalimides | 1 | 2024 | 34 | 0.060 |
Why?
|
Th2 Cells | 1 | 2010 | 1071 | 0.060 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.060 |
Why?
|
Spinal Cord Injuries | 1 | 2012 | 924 | 0.060 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 82 | 0.060 |
Why?
|
Survival Rate | 3 | 2021 | 12727 | 0.060 |
Why?
|
Pyridines | 1 | 2016 | 2872 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5662 | 0.060 |
Why?
|
Immunohistochemistry | 3 | 2014 | 11066 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6067 | 0.060 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2452 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2013 | 3388 | 0.060 |
Why?
|
Graft Survival | 2 | 2015 | 3841 | 0.050 |
Why?
|
Orthopedic Procedures | 1 | 2013 | 1276 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39121 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2013 | 1935 | 0.050 |
Why?
|
Kinetics | 3 | 2022 | 6312 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2023 | 80673 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2013 | 2047 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5694 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2014 | 14393 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6482 | 0.050 |
Why?
|
Translocation, Genetic | 2 | 2021 | 1391 | 0.050 |
Why?
|
Tenotomy | 1 | 2022 | 55 | 0.050 |
Why?
|
Plasma | 1 | 2006 | 586 | 0.050 |
Why?
|
Base Sequence | 1 | 2013 | 12404 | 0.050 |
Why?
|
Indolizines | 1 | 2022 | 30 | 0.050 |
Why?
|
Lung Neoplasms | 1 | 2007 | 13382 | 0.050 |
Why?
|
Caffeine | 1 | 2007 | 700 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 3133 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4538 | 0.050 |
Why?
|
Cyclic N-Oxides | 1 | 2022 | 72 | 0.050 |
Why?
|
Prognosis | 5 | 2022 | 29672 | 0.050 |
Why?
|
Arginine | 1 | 2006 | 921 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22129 | 0.050 |
Why?
|
Maximum Tolerated Dose | 1 | 2024 | 883 | 0.050 |
Why?
|
Pyridinium Compounds | 1 | 2022 | 81 | 0.050 |
Why?
|
Apoptosis | 2 | 2015 | 9478 | 0.050 |
Why?
|
Vimentin | 1 | 2022 | 255 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5781 | 0.050 |
Why?
|
Reactive Oxygen Species | 2 | 2007 | 2138 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9416 | 0.050 |
Why?
|
Time Factors | 2 | 2020 | 39953 | 0.050 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2022 | 144 | 0.050 |
Why?
|
Half-Life | 1 | 2022 | 649 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2024 | 2813 | 0.050 |
Why?
|
Electromyography | 2 | 2020 | 1393 | 0.050 |
Why?
|
Cholecystectomy | 1 | 2023 | 405 | 0.050 |
Why?
|
Rats, Zucker | 1 | 2001 | 131 | 0.050 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2005 | 698 | 0.050 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2022 | 175 | 0.050 |
Why?
|
Education, Continuing | 1 | 2022 | 114 | 0.050 |
Why?
|
Palmitates | 1 | 2001 | 70 | 0.050 |
Why?
|
Substrate Specificity | 2 | 2015 | 1768 | 0.050 |
Why?
|
Blood Coagulation | 2 | 2018 | 1156 | 0.050 |
Why?
|
Diglycerides | 1 | 2001 | 176 | 0.050 |
Why?
|
Extracellular Space | 1 | 2022 | 563 | 0.050 |
Why?
|
Thumb | 2 | 2013 | 232 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4849 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1603 | 0.040 |
Why?
|
Iron-Binding Proteins | 1 | 2000 | 79 | 0.040 |
Why?
|
United States | 4 | 2020 | 72337 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2007 | 3090 | 0.040 |
Why?
|
Transplantation Conditioning | 1 | 2007 | 1591 | 0.040 |
Why?
|
Methionine | 1 | 2022 | 570 | 0.040 |
Why?
|
Bone Resorption | 2 | 2014 | 723 | 0.040 |
Why?
|
Friedreich Ataxia | 1 | 2000 | 77 | 0.040 |
Why?
|
Carotid Artery Injuries | 1 | 2000 | 96 | 0.040 |
Why?
|
Fibrin | 1 | 2022 | 507 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 628 | 0.040 |
Why?
|
Osteoblasts | 2 | 2017 | 1141 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2005 | 1033 | 0.040 |
Why?
|
Bence Jones Protein | 1 | 2019 | 18 | 0.040 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2019 | 65 | 0.040 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2001 | 295 | 0.040 |
Why?
|
Bone Density | 1 | 2012 | 3548 | 0.040 |
Why?
|
Viscera | 1 | 2019 | 138 | 0.040 |
Why?
|
Fibrinogen | 1 | 2022 | 888 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4583 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2692 | 0.040 |
Why?
|
Blotting, Western | 2 | 2010 | 5033 | 0.040 |
Why?
|
Aorta | 1 | 2007 | 2040 | 0.040 |
Why?
|
Hindlimb | 1 | 2001 | 513 | 0.040 |
Why?
|
Cell Survival | 3 | 2015 | 5776 | 0.040 |
Why?
|
Palliative Care | 1 | 2014 | 3593 | 0.040 |
Why?
|
Obesity | 1 | 2001 | 12937 | 0.040 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2019 | 170 | 0.040 |
Why?
|
Prothrombin Time | 1 | 2018 | 117 | 0.040 |
Why?
|
Expressed Sequence Tags | 1 | 1999 | 250 | 0.040 |
Why?
|
Rats, Inbred Lew | 2 | 2011 | 1159 | 0.040 |
Why?
|
Guanine Nucleotides | 1 | 1998 | 55 | 0.040 |
Why?
|
Tunica Intima | 1 | 2000 | 458 | 0.040 |
Why?
|
IMP Dehydrogenase | 1 | 1998 | 33 | 0.040 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2000 | 433 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 413 | 0.040 |
Why?
|
Transforming Growth Factor beta | 2 | 1996 | 1964 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 2015 | 4822 | 0.040 |
Why?
|
Mice, Inbred CBA | 1 | 2018 | 437 | 0.040 |
Why?
|
Parotid Gland | 1 | 2019 | 176 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2018 | 204 | 0.040 |
Why?
|
Appetite | 1 | 2020 | 247 | 0.040 |
Why?
|
Angioedemas, Hereditary | 1 | 2018 | 91 | 0.040 |
Why?
|
Thinness | 1 | 2001 | 481 | 0.040 |
Why?
|
Hydrogels | 1 | 2023 | 720 | 0.040 |
Why?
|
Physical Examination | 2 | 2015 | 1255 | 0.040 |
Why?
|
Missouri | 1 | 2017 | 115 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2008 | 18926 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2019 | 370 | 0.040 |
Why?
|
Neutropenia | 1 | 2022 | 885 | 0.040 |
Why?
|
Hyponatremia | 1 | 2020 | 279 | 0.040 |
Why?
|
Visual Acuity | 1 | 2007 | 2677 | 0.030 |
Why?
|
Tropanes | 1 | 1996 | 48 | 0.030 |
Why?
|
Transcription Factors | 1 | 2016 | 12096 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1737 | 0.030 |
Why?
|
Nausea | 1 | 2020 | 679 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1045 | 0.030 |
Why?
|
Substance P | 1 | 2018 | 334 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2005 | 2443 | 0.030 |
Why?
|
Triglycerides | 2 | 2001 | 2457 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2018 | 431 | 0.030 |
Why?
|
Ribosomes | 1 | 2019 | 494 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5809 | 0.030 |
Why?
|
Transgenes | 1 | 2019 | 1008 | 0.030 |
Why?
|
Collagen | 2 | 2022 | 2635 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10755 | 0.030 |
Why?
|
Sulfonamides | 1 | 2006 | 1977 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2018 | 713 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 1998 | 350 | 0.030 |
Why?
|
Fractures, Spontaneous | 1 | 2017 | 231 | 0.030 |
Why?
|
Treatment Failure | 1 | 2022 | 2643 | 0.030 |
Why?
|
Upper Extremity | 1 | 2020 | 658 | 0.030 |
Why?
|
Spinal Cord Compression | 1 | 2017 | 234 | 0.030 |
Why?
|
Hospitals, University | 1 | 2017 | 566 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2007 | 2570 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2014 | 10421 | 0.030 |
Why?
|
Interferon Regulatory Factors | 1 | 2016 | 261 | 0.030 |
Why?
|
Virulence Factors | 1 | 2018 | 511 | 0.030 |
Why?
|
Catheterization | 1 | 2000 | 1428 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15915 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1187 | 0.030 |
Why?
|
Prostatectomy | 1 | 2023 | 1825 | 0.030 |
Why?
|
Lymphocytes | 1 | 2023 | 2603 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2001 | 2227 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2262 | 0.030 |
Why?
|
G1 Phase | 1 | 1996 | 403 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2019 | 1696 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1891 | 0.030 |
Why?
|
Organ Specificity | 1 | 2019 | 1963 | 0.030 |
Why?
|
Deafness | 1 | 1999 | 459 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2508 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15308 | 0.030 |
Why?
|
Rats | 3 | 2011 | 23713 | 0.030 |
Why?
|
Genetic Markers | 1 | 2021 | 2599 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15845 | 0.030 |
Why?
|
Patient Selection | 2 | 2020 | 4245 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2016 | 663 | 0.030 |
Why?
|
Pain, Intractable | 1 | 2015 | 132 | 0.030 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 583 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2025 | 0.030 |
Why?
|
Amyloid | 1 | 2019 | 848 | 0.030 |
Why?
|
Microsurgery | 2 | 2009 | 793 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2892 | 0.030 |
Why?
|
Phagosomes | 1 | 2015 | 199 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10203 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2015 | 13404 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1589 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2016 | 5249 | 0.030 |
Why?
|
Thoracotomy | 1 | 2015 | 366 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2392 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2015 | 350 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2656 | 0.030 |
Why?
|
Plasma Cells | 1 | 2016 | 597 | 0.030 |
Why?
|
Diarrhea | 1 | 2020 | 1318 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 17349 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1744 | 0.030 |
Why?
|
Inflammation | 2 | 2022 | 10758 | 0.030 |
Why?
|
Cell Cycle | 2 | 1998 | 2926 | 0.030 |
Why?
|
Axons | 2 | 2011 | 1671 | 0.030 |
Why?
|
Cell Lineage | 1 | 2021 | 2547 | 0.030 |
Why?
|
Cochlea | 1 | 1999 | 844 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 17598 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2021 | 2567 | 0.020 |
Why?
|
Spinal Nerves | 1 | 2012 | 90 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 2200 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2024 | 3812 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5006 | 0.020 |
Why?
|
Tibial Nerve | 1 | 2011 | 50 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2054 | 0.020 |
Why?
|
Peroneal Nerve | 1 | 2011 | 76 | 0.020 |
Why?
|
Cohort Studies | 3 | 2021 | 41486 | 0.020 |
Why?
|
Multiple Trauma | 1 | 2014 | 369 | 0.020 |
Why?
|
Self Concept | 1 | 2017 | 1046 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 987 | 0.020 |
Why?
|
Neural Conduction | 1 | 2012 | 441 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26068 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 1895 | 0.020 |
Why?
|
Collagen Type I | 1 | 2014 | 616 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1855 | 0.020 |
Why?
|
Spinal Fractures | 1 | 2017 | 704 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1756 | 0.020 |
Why?
|
Form Perception | 1 | 1992 | 175 | 0.020 |
Why?
|
Cell Differentiation | 3 | 2014 | 11505 | 0.020 |
Why?
|
Nerve Crush | 1 | 2010 | 77 | 0.020 |
Why?
|
Tumor Burden | 1 | 2016 | 1892 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2241 | 0.020 |
Why?
|
Biological Products | 1 | 2019 | 913 | 0.020 |
Why?
|
STAT4 Transcription Factor | 1 | 2010 | 94 | 0.020 |
Why?
|
Orientation | 1 | 1992 | 320 | 0.020 |
Why?
|
Discrimination Learning | 1 | 1992 | 278 | 0.020 |
Why?
|
Otolaryngology | 1 | 2017 | 693 | 0.020 |
Why?
|
Isometric Contraction | 1 | 2010 | 150 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1966 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2709 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2015 | 4168 | 0.020 |
Why?
|
S100 Proteins | 1 | 2010 | 216 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11103 | 0.020 |
Why?
|
STAT6 Transcription Factor | 1 | 2010 | 196 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2019 | 1796 | 0.020 |
Why?
|
Lung | 2 | 2019 | 9979 | 0.020 |
Why?
|
Fingers | 1 | 2012 | 506 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 531 | 0.020 |
Why?
|
Cell Communication | 1 | 1996 | 1650 | 0.020 |
Why?
|
Gene Expression | 2 | 1999 | 7567 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2011 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2621 | 0.020 |
Why?
|
Cell Cycle Proteins | 2 | 2016 | 3443 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5311 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15634 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4109 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14607 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 730 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 2009 | 218 | 0.020 |
Why?
|
Tendons | 1 | 2012 | 558 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4933 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2010 | 9518 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3591 | 0.020 |
Why?
|
Psychometrics | 1 | 2017 | 3061 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5070 | 0.020 |
Why?
|
Stromal Cells | 1 | 2013 | 1329 | 0.020 |
Why?
|
Mitochondria | 1 | 2000 | 3620 | 0.020 |
Why?
|
Motor Neurons | 1 | 2012 | 869 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2010 | 4189 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2012 | 1734 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3803 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4739 | 0.020 |
Why?
|
Autophagy | 1 | 2015 | 1326 | 0.020 |
Why?
|
3T3 Cells | 2 | 2000 | 1083 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10083 | 0.020 |
Why?
|
Electrophysiology | 1 | 2009 | 1263 | 0.020 |
Why?
|
Tacrolimus | 1 | 2010 | 735 | 0.020 |
Why?
|
Catalase | 1 | 2007 | 217 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 5993 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2012 | 815 | 0.020 |
Why?
|
Actins | 1 | 2014 | 2046 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3318 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4488 | 0.020 |
Why?
|
Critical Care | 1 | 2019 | 2690 | 0.020 |
Why?
|
Adiposity | 1 | 2016 | 1879 | 0.020 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2007 | 225 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3591 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13254 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 6987 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1480 | 0.020 |
Why?
|
Superoxides | 1 | 2007 | 388 | 0.020 |
Why?
|
Cell Shape | 1 | 2007 | 370 | 0.020 |
Why?
|
Glutathione Peroxidase | 1 | 2007 | 258 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4250 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8529 | 0.020 |
Why?
|
Tropomyosin | 1 | 2005 | 104 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 2007 | 716 | 0.020 |
Why?
|
Movement | 1 | 2012 | 1476 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 20981 | 0.020 |
Why?
|
Software | 1 | 2019 | 4433 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3548 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2007 | 594 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 691 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14676 | 0.010 |
Why?
|
Reoperation | 1 | 2015 | 4304 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 24013 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2007 | 593 | 0.010 |
Why?
|
Myosin Heavy Chains | 1 | 2005 | 403 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12975 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2007 | 731 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2007 | 1128 | 0.010 |
Why?
|
Cicatrix | 1 | 2009 | 793 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9300 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18217 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8130 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21357 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4353 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 9001 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12983 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2007 | 1674 | 0.010 |
Why?
|
Antibodies | 1 | 2010 | 2415 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6224 | 0.010 |
Why?
|
Signal Transduction | 3 | 2014 | 23415 | 0.010 |
Why?
|
Attention | 1 | 1992 | 2394 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6198 | 0.010 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2000 | 37 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8164 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22157 | 0.010 |
Why?
|
Adolescent | 3 | 2014 | 88271 | 0.010 |
Why?
|
Citric Acid Cycle | 1 | 2000 | 231 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7386 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 59199 | 0.010 |
Why?
|
Oxidative Phosphorylation | 1 | 2000 | 495 | 0.010 |
Why?
|
Growth Substances | 1 | 2000 | 759 | 0.010 |
Why?
|
Immediate-Early Proteins | 1 | 2000 | 444 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2000 | 1089 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2005 | 1160 | 0.010 |
Why?
|
Chromosomes, Human | 1 | 1999 | 442 | 0.010 |
Why?
|
Mink | 1 | 1996 | 31 | 0.010 |
Why?
|
Genes | 1 | 2000 | 1820 | 0.010 |
Why?
|
Cyclin D2 | 1 | 1996 | 98 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2000 | 941 | 0.010 |
Why?
|
Family | 1 | 2007 | 3193 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1999 | 1989 | 0.010 |
Why?
|
Isotope Labeling | 1 | 1996 | 393 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2000 | 2328 | 0.010 |
Why?
|
Cyclins | 1 | 1996 | 594 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1996 | 1123 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4565 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1996 | 1535 | 0.010 |
Why?
|
Brain | 1 | 2019 | 27097 | 0.010 |
Why?
|
Cell Line | 2 | 1996 | 15542 | 0.010 |
Why?
|
Protein Folding | 1 | 1996 | 869 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1996 | 1130 | 0.010 |
Why?
|
Epithelium | 1 | 1996 | 1603 | 0.010 |
Why?
|
Psychophysics | 1 | 1992 | 291 | 0.010 |
Why?
|
Color Perception | 1 | 1992 | 213 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4612 | 0.010 |
Why?
|
RNA | 1 | 2000 | 2708 | 0.010 |
Why?
|
Genetic Engineering | 1 | 1996 | 929 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2000 | 2877 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16572 | 0.000 |
Why?
|
Cell Division | 1 | 1996 | 4451 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1996 | 6123 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1998 | 3700 | 0.000 |
Why?
|
Calcium | 1 | 2000 | 5720 | 0.000 |
Why?
|
Reaction Time | 1 | 1992 | 2087 | 0.000 |
Why?
|
Phosphorylation | 1 | 1996 | 8303 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1996 | 3666 | 0.000 |
Why?
|